QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 wells-fargo-initiates-coverage-on-bruker-with-overweight-rating-announces-price-target-of-78

Wells Fargo analyst Brandon Couillard initiates coverage on Bruker (NASDAQ:BRKR) with a Overweight rating and announces Pric...

 td-cowen-maintains-hold-on-bruker-lowers-price-target-to-72

TD Cowen analyst Max Masucci maintains Bruker (NASDAQ:BRKR) with a Hold and lowers the price target from $74 to $72.

 bruker-announced-a-minority-investment-in-novalix-a-preclinical-contract-research-organization-specializing-in-drug-discovery-services-financial-details-of-the-investment-were-not-disclosed

The minority investment aims to accelerate the growth and further expansion of NovAliX, particularly within Europe and the Unit...

 bruker-q2-2024-adj-eps-052-inline-sales-800700m-beat-796541m-estimate

Bruker (NASDAQ:BRKR) reported quarterly earnings of $0.52 per share which met the analyst consensus estimate. The company repo...

 citigroup-maintains-buy-on-bruker-lowers-price-target-to-80

Citigroup analyst Patrick Donnelly maintains Bruker (NASDAQ:BRKR) with a Buy and lowers the price target from $95 to $80.

 goldman-sachs-maintains-sell-on-bruker-lowers-price-target-to-60

Goldman Sachs analyst Matthew Sykes maintains Bruker (NASDAQ:BRKR) with a Sell and lowers the price target from $72 to $60.

 cellens-is-collaborating-with-bruker-bioafm-a-business-unit-of-bruker-to-develop-the-worlds-first-clinical-diagnostic-tests-that-leverage-multi-parametric-single-cell-biophysical-markers-and-machine-learning

Based on cellular biophysical markers attained using Bruker's advanced atomic force microscopy, Cellens is developing its p...

 bruker-launches-neoflex-maldi-tof-system-for-spatial-biology-mass-spec-imaging-msi-applications-timstof-ultra-2-to-enable-new-research-paradigms-in-single-cell-and-subcellular-proteomics

At the 72nd ASMS meeting, Bruker Corporation (NASDAQ:BRKR) announced the launch of a novel, high-performance MALDI-TOF/TOF syst...

 why-bruker-brkr-shares-are-falling-during-thursdays-session

Bruker shares are trading lower by 6.6% during Thursday's session. The company announced a public offering of 6 million sha...

 reported-earlier-bruker-prices-public-offering-of-6m-shares-of-common-stock

Bruker intends to use the net proceeds from the offering to reduce indebtedness following its recent strategic acquisitions, in...

 bruker-announces-public-offering-of-6m-shares-of-common-stock

Bruker Corporation ("Bruker" or the "Company") (NASDAQ:BRKR) today announced the launch of an underwritten regi...

 stifel-maintains-hold-on-bruker-lowers-price-target-to-77

Stifel analyst Daniel Arias maintains Bruker (NASDAQ:BRKR) with a Hold and lowers the price target from $81 to $77.

 b-of-a-securities-maintains-buy-on-bruker-lowers-price-target-to-90

B of A Securities analyst Derik De Bruin maintains Bruker (NASDAQ:BRKR) with a Buy and lowers the price target from $95 to $90.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION